Equities
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.90
  • Today's Change0.00 / 0.00%
  • Shares traded70.00k
  • 1 Year change+106.90%
  • Beta0.4427
Data delayed at least 15 minutes, as of Mar 04 2026 06:46 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Regent Pacific Group Ltd, formerly Endurance RP Ltd is an investment holding company principally engaged in biopharma and investment businesses. The Company operates its business through two segments. The Biopharma segment is engaged in the research, development, manufacture, marketing and sale of pharmaceutical products. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The Company is also engaged in aging research and developing artificial intelligence (AI) models and tool products related to aging research. It offers aging and longevity clocks to the longevity clinics, preventative medicine organizations, health clubs, insurance companies, and aging research institutions.

  • Revenue in HKD (TTM)7.16m
  • Net income in HKD-31.88m
  • Incorporated1991
  • Employees17.00
  • Location
    Regent Pacific Group Ltd8FHenley Building 5 Queen's Road Central Hong KongHKG
  • Phone+852 25146111
  • Fax+852 28104792
  • Websitehttps://www.endurancerp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sanai Health Industry Group Co Ltd108.77m-37.78m60.39m147.00--0.1737--0.5553-0.247-0.11840.7112.270.19948.979.71663,207.20-7.703.50-10.975.0017.6137.40-38.6010.862.58-6.860.14870.00-20.920.8085-176.60---9.02--
PuraPharm Corp Ltd346.76m-38.56m168.81m469.00--1.2311.580.4868-0.0976-0.09760.87780.25680.47491.396.98723,920.70-5.28-6.50-15.35-14.9753.9359.22-11.12-14.080.3313-1.140.7865---6.09-11.3066.59---29.92--
Kontafarma China Holdings Ltd891.73m-362.77m173.25m655.00--0.2529--0.1943-0.065-0.0650.15980.12260.62694.437.061,296,115.00-29.24-2.95-39.76-4.3855.3655.42-46.64-7.850.8036--0.2753--10.93-0.5183-161.89---31.47--
Extrawell Pharmaceutical Holdings Ltd52.65m-337.89m204.00m161.00--0.2285--3.88-0.1351-0.13520.02190.35010.042210.545.89322,975.50-27.003.07-28.133.2142.4147.65-640.5359.7713.00-0.0370.146---6.21-6.50236.7021.7580.07--
Tianda Pharmaceuticals Ltd310.50m-67.37m236.50m624.00--0.4867--0.7617-0.0313-0.03130.14440.2260.39312.845.14442,937.20-8.57---12.38--42.76---21.80--0.6900-15.810.2183---37.99---154.07------
Hin Sang Group (Interntnl) Hldng Co Ltd95.53m-40.10m239.10m185.00--1.69--2.50-0.0367-0.03670.08750.12990.16792.4212.62459,278.80-7.03-5.77-13.64-8.4167.2858.19-41.89-36.550.0735-0.33330.7032---0.7882-12.21-34.48---50.36--
Shenzhen Neptunus Intrlng Bi tchnq CoLtd1.13bn7.01m261.77m1.47k37.300.32576.210.23190.00420.00420.67260.4790.7833.685.65759,990.90-0.42952.52-0.63293.7629.1243.41-0.54863.331.482.030.1157139.17-2.18-0.73563.68-15.97-7.87--
Regent Pacific Group Ltd7.16m-31.88m262.63m17.00------36.70-0.1389-0.13890.0312-0.11171.20--6.96420,948.40-535.26-47.86---61.88-----445.46-1,658.64---11.90----153.632.1782.11---5.59--
Wai Yuen Tong Medicine Holdings Ltd721.27m-13.83m382.54m726.00--0.32345.170.5304-0.0123-0.01230.64111.050.41651.419.68950,292.50-0.7998-1.81-1.06-3.1049.8744.67-1.92-11.190.7806--0.2033---4.923.73126.62-56.1631.89--
China NT Pharma Group Co Ltd21.20m-80.60m498.94m21.00------23.53-0.2338-0.23380.0489-0.46670.0546--3.09963,780.60-20.76-10.31----51.27---380.13-97.110.0447-0.39737.95--415.34-24.38-59.32---71.03--
Uni-Bio Science Group Ltd589.59m91.35m644.89m504.007.091.685.631.090.01520.01520.09760.06411.133.629.181,210,657.0017.516.2122.178.5682.1980.7215.494.963.2259.390.221,633.5814.0821.4316.79102.0432.65--
Zhongzhi Pharmaceutical Holdings Ltd2.28bn23.36m656.34m2.49k27.450.53194.540.28780.02770.02772.701.431.052.666.45884,979.901.096.771.6810.4757.1959.641.035.911.0651.800.113438.978.0510.54-41.51-3.6513.6210.79
Data as of Mar 04 2026. Currency figures normalised to Regent Pacific Group Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
British & American Investment Trust Plc (Invt Mgmt)as of 30 Jun 202521.30k0.01%
Data from 30 Jun 2025 - 30 Jun 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.